Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105566319A details efficient moxifloxacin intermediate synthesis with high chiral purity and reduced costs for reliable supply chains.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN110845305A details a novel organoaluminum catalyst for high-yield L-menthol production, offering significant cost reduction and supply chain reliability for fine chemical manufacturers.
Patent CN1219758C reveals a scalable inclusion resolution method for di-tert-butyl thiosulfinate, offering dual-configuration access and significant cost reduction potential.
Patent CN1259941A details a streamlined route for 3-N,N-dicyclobutylamino-8-fluoro-benzopyran derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced catalytic reduction route for Rivastigmine Tartrate offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel chiral resolution route for Levosimendan intermediates ensures high optical purity and scalable production for global pharmaceutical supply chains.
Patent CN106432199B reveals ultrasonic resolution for high-purity Ondansetron. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel chemical route for D-norvaline from n-pentanoic acid offers cost reduction in API manufacturing and high purity for chiral drug synthesis.
Patent CN106366031B details a novel chiral resolution route for (S)-Oxiracetam offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN1288133C reveals a 4-step route to Levetiracetam, significantly improving yield and safety over traditional 6-step methods for reliable API supply.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.
This report analyzes patent CN101100462A for levocetirizine production, highlighting cost-effective resolution and scalable alkylation strategies for global pharmaceutical supply chains.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.